Concentrations of Prioritized Pharmaceuticals in Effluents from 50 Large Wastewater Treatment Plants in the US and Implications for Risk Estimation

We measured the concentrations of 56 medicinal active ingredients (APIs) and 7 metabolites (including 50 preferential APIs) in a composite wastewater sample collected over 24 hours from 50 very large municipal wastewater treatment facilities in the United States . Hydrochlorothiazide was found in each sample analyzed. In addition, metoprolol, atenolol and carbamazepine were found in more than 90% of the samples. The highest concentration of valsartan was 5300 ng / L, and the average concentration of all 50 samples was the highest (1600 ng / L). The six highest ratios of measured concentrations to the therapeutic concentration are the antihypertensive APIs (lisinopril, hydrochlorothiazide, valsartan, atenolol, enalapril and metoprolol), but in both cases the ratio is less than 0.003. These ratios indicate that healthy adults are less likely to be exposed to environmental and drinking water. For the four analytes (sertraline, propranolol, demethylproline and valsartan) the ratio of the measured concentration to the therapeutic plasma concentration is 0.1 to 1, which implies that further studies of environmental exposure are required Respectively. The potential impact of aquatic organisms on a small number of analytes The rationale is to extend these conclusions to aquatic exposure of prescription drugs, including those not previously investigated.

You may need a PDF reader to view the files on this page. For details, please refer to EPA's About PDF page.

Wastewater guidelines are national standards for discharging industrial wastewater to surface water and public treatment plants (municipal waste water treatment plants). We issued guidelines on wastewater from existing source and new source categories in accordance with Chapter 3 of the Water Pollution Control Law. Standards are technology based (ie, they are based on the performance of processing and control technology), they are not based on the risk or impact of receiving water

Human and veterinary drugs and their metabolites are due to their overproduction and the indiscriminate use of ubiquitous environmental pollutants present in groundwater and surface waters at concentrations ranging from ng to μg. In three sewage treatment plants (WWTP), the drug concentration of ibuprofen reached 1.3 μg, diclofenac 0.99 μg, and carbamazepine 0.95 μg. French scientists have shown that the drug concentration in the surface water is two to three times higher than that of the treated drinking water.

Along with increasing sensitivity of analytical methods to measure these chemicals at very low concentrations, many studies have found wastewater, various water sources, and trace concentrations of drinking water. The concentrations of surface water, groundwater and partially treated water are usually less than 0.1 μg / l (or 100 ng / l) and the concentration of treated water is usually less than 0.05 μg / l (or 50 ng / l) . These investigations indicate that there are many sources of water that are subject to wastewater, although at a low concentration.

We measured the concentrations of 56 medicinal active ingredients (APIs) and 7 metabolites (including 50 preferential APIs) in a composite wastewater sample collected over 24 hours from 50 very large municipal wastewater treatment facilities in the United States . Hydrochlorothiazide was found in each sample analyzed. In addition, metoprolol, atenolol and carbamazepine were found in more than 90% of the samples. The highest concentration of valsartan was 5300 ng / L, and the average concentration of all 50 samples was the highest (1600 ng / L). The six highest ratios of measured concentrations to the therapeutic concentration are the antihypertensive APIs (lisinopril, hydrochlorothiazide, valsartan, atenolol, enalapril and metoprolol), but in both cases the ratio is less than 0.003. These ratios indicate that healthy adults are less likely to be exposed to environmental and drinking water

Prior drug concentrations in the wastewater of 50 large sewage treatment plants in the United States and importance of risk assessment